Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies

PURPOSE: Cardiac dysfunction, particularly QT interval prolongation, has been observed with tyrosine kinase inhibitors approved to treat chronic myeloid leukemia. This study examines the effects of ponatinib on cardiac repolarization in patients with refractory hematological malignancies enrolled in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sonnichsen, Daryl, Dorer, David J., Cortes, Jorge, Talpaz, Moshe, Deininger, Michael W., Shah, Neil P., Kantarjian, Hagop M., Bixby, Dale, Mauro, Michael J., Flinn, Ian W., Litwin, Jeffrey, Turner, Christopher D., Haluska, Frank G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer-Verlag 2013
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3668123/
https://ncbi.nlm.nih.gov/pubmed/23609479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2160-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky